SynCardia gains FDA OK for portable artificial heart driver The FDA has granted SynCardia Systems approval to market the Freedom driver for use with the company's Total Artificial Heart. The portable driver, which already has marketing approval in Canada and Europe, allows clinically stable patients implanted with the company's Total Artificial Heart to leave the hospital while awaiting a transplant.Arizona Daily Star (Tucson)
Learn How Analytics Outsourcing Can Become a Competitive Advantage
You've heard it before: outsourcing your analytics can improve customer segmentation, pinpoint cross- and upselling opportunities, and find new ways to deliver value--and do so more efficiently and effectively. Yet few med device companies do this today. However, a reticence to outsource analytics may prove to be a strategic blunder in the coming years. View this video to learn how analytics outsourcing can be a competitive advantage for your company.
Business & Market Trends
Group looks to invest up to $60M in life sciences startups A fund worth as much as $60 million is being raised by the New York City Economic Development Corp. in an effort to foster biotech innovation in the city. The group plans to invest the money in early-stage companies developing diagnostics, medical devices and other life sciences technologies.Xconomy/New York
MassDevice.com speaks to 3M's Deb Rectenwald, St. Jude Medical's Philip Ebeling and Nadim Yared, CEO of CVRx, about the environment for medtech M&A and other trends affecting the industry. Listen to the podcast.
Follow AdvaMed on Google+ Stay updated on industry news and educational opportunities -- receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Network with industry experts and leaders. Our Google+ page is interactive and incorporates updates from key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Follow us on Google+.